Preventing DKA with continuous ketone monitoring in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a dual continuous ketone and glucose monitor to help prevent diabetic ketoacidosis (DKA) in people with type 1 diabetes who are starting SGLT2 inhibitor treatment. SGLT2 inhibitors are a newer type of diabetes medicine, but they can increase the risk of DKA. The device may make using these medicines safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- You must have type 1 diabetes, diagnosed for at least 3 months.
- You must be using an insulin pump or multiple daily insulin injections.
- You must have a recent lab result showing your HbA1c between 7% and 9%.
- You must not have used SGLT2 inhibitor medications before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called dapagliflozin (a type of SGLT2 inhibitor) can be used safely in people with type 1 diabetes by checking blood ketone levels. It may help find a way to lower the risk of a serious condition called ketoacidosis while using this medication.
This study looks at how well a simple urine test can track chronic kidney disease (CKD) and whether SGLT2 inhibitors (a type of diabetes medicine also used for kidney protection) work in real life. It might help find better ways to manage your condition.
This study tests a device that monitors ketone levels to help reduce the risk of diabetic ketoacidosis (DKA) for people with type 1 diabetes who are taking a class of medications called SGLT-2 inhibitors. The goal is to see if regular ketone tracking can make these medications safer.
This study tests a new sensor that continuously measures ketone levels in people with type 1 diabetes who are also taking SGLT2 inhibitors. It aims to see if the sensor can help prevent diabetic ketoacidosis.
This study is testing a sensor to help prevent diabetic ketoacidosis (DKA), a serious complication of type 1 diabetes. If you join, you'll wear a sensor that checks your glucose and ketones.
This study tests if a special monitoring system can help people with type 1 diabetes use SGLT2i medications safely, alongside insulin and a continuous glucose monitor.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.